𝛼SK or Search

ENTITY

VISEN Pharmaceuticals (2561 HK)

13

Analysis

Health Care • China

VISEN Pharmaceuticals is an innovative biopharmaceutical company focused on endocrine diseases. It develops and commercializes therapies for conditions such as pediatric growth hormone deficiency, achondroplasia, and chronic hypoparathyroidism. The company was founded in 2018 and is headquartered in Suzhou, China.

more

Refresh

Exchange Announcement • 05 Oct 2026 19:58

List Of Directors And Their Roles And Functions

Exchange Announcement • 05 Oct 2026 19:54

Resignation Of Non-Executive Director

Exchange Announcement • 09 Sep 2026 16:30

2026 Interim Report

Exchange Announcement • 27 Aug 2026 22:17

List Of Directors And Their Roles And Functions

Exchange Announcement • 27 Aug 2026 22:14

(1) Interim Results Announcement For The Six Months Ended June 30, 2026; (2) Resignation Of Director; And (3) Change Of Composition Of The Board Committees

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x